A 6-month mixed-effect pharmacokinetic model for post-transplant intravenous anti-hepatitis B immunoglobulin prophylaxis.

Drug Des Devel Ther · 2017 · PMC5513836 · PMID 28744101

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

26 , 27 The influence of HBsAg on the HBIG CL is considered as a covariate for dose individualization during the first week or even month after the transplantation when the viral effect on the HBIG elimination may be significant.

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.